SOLESENCE, INC. - Director's Dealing 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2008-05-12

Reporting Person: HAINES ROBERT W (VP - Operations)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-05-12	Stock Option (right to buy)	$3.14	A	23000	Acquired	2018-05-12	Common Stock (23000)	Direct

Security	Shares	Ownership
Common Stock	2558	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.1875	2011-01-22	Common Stock (30000)	30000	Direct
Stock Option (right to buy)	$6.65	2012-01-03	Common Stock (40000)	40000	Direct
Stock Option (right to buy)	$3.66	2013-03-24	Common Stock (30000)	30000	Direct
Stock Option (right to buy)	$5.55	2014-10-11	Common Stock (11000)	11000	Direct
Stock Option (right to buy)	$5.84	2016-07-24	Common Stock (20000)	20000	Direct
Stock Option (right to buy)	$6.03	2015-09-27	Common Stock (10000)	10000	Direct
Stock Appreciation Right	$6.01	2016-09-27	Common Stock (15000)	15000	Direct
Stock Option (right to buy)	$4.48	2017-11-06	Common Stock (15000)	15000	Direct

F1: Subject to certain restrictions, beginning on this date, options vest in five equal installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F3: Subject to certain restrictions, beginning on this date, these stock appreciation rights vest in three equal annual installments.